期刊的影响因子--文章列表

期刊文章列表
Wenbin Kuang^1,2，Haolin Zhang^1,2，Xiao Wang^1,2，Peng Yang^1,2（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization,China Pharmaceutical University；Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University）.Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis[J].Acta Pharmaceutica Sinica B,2022,第8期 Cuixia Zheng¹，Xinxin Liu^2,1，Yueyue Kong¹，Lei Zhang³，Qingling Song¹，Hongjuan Zhao¹，Lu Han¹，Jiannan Jiao¹，Qianhua Feng^1,4，Lei Wang^2,1,4,5（School of Pharmaceutical Sciences,Zhengzhou University；Luoyang Central Hospital Affiliated to Zhengzhou University；Department of Gynecology,the First Affiliated Hospital of Zhengzhou University；Key Laboratory of Advanced Drug Preparation Technologies,Ministry of Education,School of Pharmaceutical Sciences,Zhengzhou University；Tumor Immunity and Biomaterials Advanced Medical Center,Zhengzhou University）.Hyperthermia based individual in situ recombinant vaccine enhances lymph nodes drainage for de novo antitumor immunity[J].Acta Pharmaceutica Sinica B,2022,第8期 Minglu Zhou，Qingting Zuo，Yuan Huang，Lian Li（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology,West China School of Pharmacy,Sichuan University）.Immunogenic hydrogel toolkit disturbing residual tumor “seeds” and pre-metastatic “soil” for inhibition of postoperative tumor recurrence and metastasis[J].Acta Pharmaceutica Sinica B,2022,第8期 Baeksun Kim^1,2，Sung Hyun Tag^1,2，Eunjoo Nam³，Suji Ham^1,2，Sujin Ahn³，Juhwan Kim³，Doo-Wan Cho⁴，Sangjoon Lee^1,3，Young-Su Yang⁴，Seung Eun Lee⁵，Yong Sik Kim⁶，Il-Joo Cho^2,7，Kwang Pyo Kim⁸，Su-Cheol Han⁴，Heh-In Im^1,2,3（Convergence Research Center for Diagnosis,Treatment and Care System of Dementia (DTC),Korea Institute of Science and Technology (KIST)；Division of Bio-Medical Science & Technology,KIST School,Korea University of Science and Technology (UST)；Center for Neuroscience，KIST；Animal Model Research Center,Jeonbuk Department of Inhalation Research,Korea Institute of Toxicology (KIT)，Korea Research Institute of Chemical Technology (KRICT)；Research Animal Resource Center，KIST；Department of Pharmacology,Seoul National University College of Medicine；Center for BioMicrosystems，KIST；Department of Applied Chemistry,Kyung Hee University）.SYNCRIP controls miR-137 and striatal learning in animal models of methamphetamine abstinence[J].Acta Pharmaceutica Sinica B,2022,第8期 Honglin Tang^1,2，Yanan Xue^1,2，Bowen Li²，Xiaojie Xu²，Fu Zhang^1,3，Jiajing Guo²，Qijun Li¹，Tingting Yuan²，Yuan Chen²，Yubin Pan¹，Yuan Ping²，Da Li¹（Department of Medical Oncology,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University；College of Pharmaceutical Sciences,Zhejiang University；Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital,Zhejiang University）.Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma[J].Acta Pharmaceutica Sinica B,2022,第8期 Yaosheng Li¹，Honghui Wu¹，Xinchi Jiang^1,2，Yunfei Dong¹，Juanjuan Zheng¹，Jianqing Gao^1,2,3（Institute of Pharmaceutics,College of Pharmaceutical Sciences,Zhejiang University；Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University；Hangzhou Institute of Innovative Medicine,Zhejiang University）.New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders：Combining with intranasal delivery[J].Acta Pharmaceutica Sinica B,2022,第8期 Sai-Qi Wang^1,2，Qiu-Xu Teng³，Shuai Wang⁴，Zi-Ning Lei³，Hui-Hui Hu¹，Hui-Fang Lv¹，Bei-Bei Chen¹，Jian-Zheng Wang¹，Xiao-Jing Shi⁵，Wei-Feng Xu¹，Hong-Min Liu^4,2，Xiao-Bing Chen^1,2，Zhe-Sheng Chen³，Bin Yu^4,2（Department of Oncology,the Affiliated Cancer Hospital of Zhengzhou University,Henan Cancer Hospital,Henan Cancer Institute；State Key Laboratory of Esophageal Cancer Prevention & Treatment,Zhengzhou University；College of Pharmacy and Health Sciences,St. John's University；School of Pharmaceutical Sciences,Zhengzhou University；Laboratory Animal Center,Academy of Medical Science,Zhengzhou University）.Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent,specific and orally active P-glycoprotein（P-gp）inhibitor[J].Acta Pharmaceutica Sinica B,2022,第8期 Longlong Zhang^1,2，Yuefei Zhu¹，Xunbin Wei³，Xing Chen^1,2，Yang Li^1,2，Ying Zhu¹，Jiaxuan Xia¹，Yiheng Huang¹，Yongzhuo Huang⁴，Jianxin Wang^1,2,5，Zhiqing Pang^1,2（Department of Pharmaceutics,School of Pharmacy,Fudan University；Key Laboratory of Smart Drug Delivery,Ministry of Education；State Key Laboratory of Oncogenes and Related Genes,Shanghai Cancer Institute,Med-X Research Institute and School of Biomedical Engineering,Shanghai Jiao Tong University；State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；Institute of Materia Medica,Academy of Chinese and Western Integrative Medicine,Fudan University）.Nanoplateletsomes restrain metastatic tumor formation through decoy and active targeting in a preclinical mouse model[J].Acta Pharmaceutica Sinica B,2022,第8期 Yuan Gao，Jia-bo Wang（School of Traditional Chinese Medicine,Capital Medical University）.Commentary：Indirect action pattern：A remote and cross-organ pharmacological mechanism for drug innovation[J].Acta Pharmaceutica Sinica B,2022,第8期 Jiabing Wang，Lili Huang，Chanchan Chen，Ge Li，Jingwen Xie，Mengya Shen，Qian Chen，Wulan Li，Wenfei He，Peihong Qiu，Jianzhang Wu（Chemical Biology Research Center）.Author correction to ‘Design，synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents’ [Acta Pharmaceutica Sinica B 9 (2019) 335e350][J].药学学报(英文版),2022,第8期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第8期 Editoral Office of Acta Pharmaceutica Sinica.Information for Authors[J].药学学报(英文版),2022,第8期 Xiaoting Shan^1,2，Xiang Gong¹，Jie Li^1,3，Jingyuan Wen⁴，Yaping Li^1,2，Zhiwen Zhang^1,3,2（State Key Laboratory of Drug Research & Center of Pharmaceutics,Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmacy,University of Chinese Academy of Sciences；Yantai Key Laboratory of Nanomedicine & Advanced Preparations,Yantai Institute of Materia Medica；School of Pharmacy,University of Auckland）.Current approaches of nanomedicines in the market and various stage of clinical translation[J].Acta Pharmaceutica Sinica B,2022,第7期 Siyue Zhang^1,2,3,4，Fangyuan Xie^1,5，Kaichun Li⁶，He Zhang¹，You Yin⁷，Yuan Yu¹，Guangzhao Lu¹，Shihao Zhang⁸，Yan Wei³，Ke Xu³，Yan Wu⁹，Hong Jin¹⁰，Lan Xiao¹¹，Leilei Bao⁵，Can Xu¹²，Yulin Li^8,13，Ying Lu¹，Jie Gao^2,3（Department of Pharmacy,Naval Medical University；Changhai Clinical Research Unit,Shanghai Changhai Hospital,Naval Medical University；Institute of Translational Medicine,Shanghai University；Unit for Drug and Instrument Supervision and Inspection of Wuxi Joint Logistic Support Center；Department of Pharmacy,Shanghai Eastern Hepatobiliary Surgery Hospital,Naval Medical University；Department of Oncology,Shanghai Fourth People’s Hospital,School of Medicine,Tongji University；Department of Neurology,Changzheng Hospital,Naval Medical University；Key Laboratory for Ultrafine Materials of Ministry of Education,Engineering Research Center for Biomedical Materials of Ministry of Education,School of Materials Science and Engineering,East China University of Science and Technology；Department of Biomaterial,College of Life Sciences,Mudanjiang Medical University；Department of Laboratory Medicine,Hongqi Hospital,Mudanjiang Medical College；Centre for Biomedical Technologies,Queensland University of Technology；Department of Gastroenterology,Shanghai Changhai Hospital,Naval Medical University；Wenzhou Institute of Shanghai University）.Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization[J].Acta Pharmaceutica Sinica B,2022,第7期 Ziying Sun^1,2，Qianqian Liu³，Zhongyang Lv^1,2，Jiawei Li^1,2，Xingquan Xu^1,2，Heng Sun^1,2，Maochun Wang^1,2，Kuoyang Sun^1,2，Tianshu Shi^1,2，Zizheng Liu^1,2，Guihua Tan^1,2，Wenqiang Yan^1,2，Rui Wu^1,2，Yannick Xiaofan Yang^1,4，Shiro Ikegawa^1,5，Qing Jiang^1,2，Yang Sun³，Dongquan Shi^1,2（State Key Laboratory of Pharmaceutical Biotechnology,Department of Sports Medicine and Adult Reconstructive Surgery,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School；Laboratory for Bone and Joint Disease,Model Animal Research Center (MARC),Nanjing University；State Key Laboratory of Pharmaceutical Biotechnology,Department of Biotechnology and Pharmaceutical Sciences,School of Life Science,Nanjing University；Drum Tower of Clinical Medicine,Nanjing Medical University；Laboratory for Bone and Joint Diseases,RIKEN Center for Integrative Medical Science (IMS，RIKEN)）.Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling[J].Acta Pharmaceutica Sinica B,2022,第7期 Jian He¹，Yu Huo¹，Zhikun Zhang¹，Yiqun Luo¹，Xiuli Liu¹，Qiaoying Chen¹，Pan Wu¹，Wei Shi²，Tao Wu³，Chao Tang¹，Huixue Wang¹，Lan Li¹，Xiyu Liu¹，Yong Huang¹，Yongxiang Zhao¹，Lu Gan¹，Bing Wang⁴，Liping Zhong¹（National Center for International Research of Biotargeting Theranostics,Guangxi Key Laboratory of Biotargeting Theranostics,Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy,Guangxi Talent Highland of Biotargeting Theranostics,Guangxi Medical University；The First Affiliated Hospital,Guangxi University of Chinese Medicine；The First People's Hospital of Changde City；Department of Spine Surgery,the Second Xiangya Hospital of Central South University）.Generation of αGal-enhanced bifunctional tumor vaccine[J].Acta Pharmaceutica Sinica B,2022,第7期 Xu-Nian Wu¹，Qian Zhou¹，Ya-Dan Huang¹，Xi Xie²，Zhe Li¹，Yinuo Wu¹，Hai-Bin Luo^1,2（School of Pharmaceutical Sciences,Sun Yat-sen University；Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute,School of Pharmaceutical Sciences,Hainan University）.Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia[J].Acta Pharmaceutica Sinica B,2022,第7期 Ashima Dhiman，Rupam Sharma，Rajesh K.Singh（Department of Pharmaceutical Chemistry,Shivalik College of Pharmacy,IKG Punjab Technical University）.Target-based anticancer indole derivatives and insight into structure-activity relationship：A mechanistic review update（2018—2021）[J].Acta Pharmaceutica Sinica B,2022,第7期 Fenglin Jiang，Chen Zhou，Yan Li，Haidong Deng，Ting Gong，Jingjing Chen，Tianjiao Chen，Jinling Yang，Ping Zhu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines,NHC Key Laboratory of Biosynthesis of Natural Products,CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs,Institute of Materia Medica,Chinese Academy of Medical Sciences ＆ Peking Union Medical College）.Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM[J].Acta Pharmaceutica Sinica B,2022,第7期 Yuhong Cao^1,2，Jiahao Fang¹，Yiwei Shi¹，Hui Wang¹，Xiaofei Chen¹，Yue Liu¹，Zhenyu Zhu¹，Yan Cao¹，Zhanying Hong¹，Yifeng Chai¹（School of Pharmacy,Second Military Medical University,Shanghai Key Laboratory for Pharmaceutical Metabolites Research；Zhejiang Institute for Food and Drug Control）.Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor[J].Acta Pharmaceutica Sinica B,2022,第7期 Duxin Sun¹，Wei Gao¹，Hongxiang Hu¹，Simon Zhou²（Department of Pharmaceutical Sciences,College of Pharmacy,University of Michigan；Translational Development and Clinical Pharmacology,Bristol Meyer Squibb Company）.Why 90% of clinical drug development fails and how to improve it?[J].Acta Pharmaceutica Sinica B,2022,第7期 Bin Tu^1,2，Huiyuan Wang¹，Xinran An^1,3，Jingkun Qu^1,4，Qianqian Li^1,5，Yanrong Gao^1,2，Mingjie Shi¹，Hong Qiu¹，Yongzhuo Huang^1,2,6,7,8（State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；University of Chinese Academy of Sciences；University of Michigan College of Pharmacy；School of Chinese Materia Medica,Nanjing University of Chinese Medicine；Nanchang University College of Pharmacy；Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences；NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients；Taizhou University,School of Advanced Study,Institute of Natural Medicine and Health Product）.Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants[J].Acta Pharmaceutica Sinica B,2022,第7期 Ningna Weng¹，Siyuan Qin²，Jiayang Liu²，Xing Huang³，Jingwen Jiang²，Li Zhou²，Zhe Zhang²，Na Xie²，Kui Wang²，Ping Jin²，Maochao Luo²，Liyuan Peng²，Edouard C.Nice⁴，Ajay Goel⁵，Suxia Han⁶，Canhua Huang²，Qing Zhu¹（Department of Abdominal Oncology,West China Hospital of Sichuan University；State Key Laboratory of Biotherapy and Cancer Center,West China Hospital,West China School of Basic Medical Sciences & Forensic Medicine,Sichuan University,Collaborative Innovation Center for Biotherapy；Department of Pancreatic Surgery,West China Hospital of Sichuan University；Department of Biochemistry and Molecular Biology,Monash University；Department of Molecular Diagnostics and Experimental Therapeutics,Beckman Research Institute of City of Hope,Biomedical Research Center；Department of Oncology,the First Affiliated Hospital,Xi'an Jiaotong University）.Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma[J].Acta Pharmaceutica Sinica B,2022,第7期 Tianming Ren^1,2，Runzhi Li^1,2，Liqiang Zhao²，J.Paul Fawcett¹，Dong Sun^1,2，Jingkai Gu^1,3,2（Research Center for Drug Metabolism,School of Life Sciences,Jilin University；Beijing Institute of Drug Metabolism；State Key Laboratory of Supramolecular Structure and Materials,Jilin University）.Biological fate and interaction with cytochromes P450 of the nanocarrier material, D-α-tocopheryl polyethylene glycol 1000 succinate[J].Acta Pharmaceutica Sinica B,2022,第7期 Sinan Ma¹，Jianai Ji¹，Yuanyuan Tong¹，Yuxuan Zhu¹，Junwei Dou¹，Xian Zhang¹，Shicheng Xu¹，Tianbao Zhu¹，Xiaoli Xu^1,2，Qidong You^1,2，Zhengyu Jiang^1,2（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization,China Pharmaceutical University；Department of Medicinal Chemistry,School of Pharmacy,China Pharmaceutical University）.Non-small molecule PROTACs（NSM-PROTACs）：Protein degradation kaleidoscope[J].Acta Pharmaceutica Sinica B,2022,第7期 Qing He，Hua Gao，Dejiang Tan，Heng Zhang，Jun-zhi Wang（National Institutes for Food and Drug Control,State Key Laboratory for Evaluation and Standardization of Innovative Vaccines and Biotechnology Products）.mRNA cancer vaccines：Advances, trends and challenges[J].Acta Pharmaceutica Sinica B,2022,第7期 Qichao Yang¹，Xianbin Ma²，Yao Xiao¹，Tian Zhang²，Leilei Yang¹，Shaochen Yang¹，Mengyun Liang²，Shuo Wang¹，Zhizhong Wu¹，Zhigang Xu²，Zhijun Sun¹（The State Key Laboratory Breeding Base of Basic Science of Stomatology Hubei-MOST & Key Laboratory of Oral Biomedicine Ministry of Education,School & Hospital of Stomatology,Wuhan University；Key Laboratory of Luminescence Analysis and Molecular Sensing Southwest University,Ministry of Education，School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices,Southwest University）.Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity[J].Acta Pharmaceutica Sinica B,2022,第7期 Yi Zhu^1,2，Na Li¹，Mingyang Huang²，Xi Chen²，Yu A.An¹，Jianping Li³，Shangang Zhao¹，Jan-Bernd Funcke¹，Jianhong Cao⁴，Zhenyan He⁴，Qingzhang Zhu¹，Zhuzhen Zhang¹，Zhao V.Wang³，Lin Xu^5,6，Kevin W.Williams⁴，Chien Li⁷，Kevin Grove⁷，Philipp E.Scherer^1,8（Touchstone Diabetes Center,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Children's Nutrition Research Center,Department of Pediatrics,Baylor College of Medicine；Division of Cardiology,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Division of Hypothalamic Research,Department of Internal Medicine,the University of Texas Southwestern Medical Center at Dallas；Quantitative Biomedical Research Center,Department of Population and Data Sciences,the University of Texas Southwestern Medical Center at Dallas；Department of Pediatrics,the University of Texas Southwestern Medical Center at Dallas；Novo Nordisk Research Center；Department of Cell Biology,the University of Texas Southwestern Medical Center at Dallas）.Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention[J].Acta Pharmaceutica Sinica B,2022,第7期首页上一页 2 3 4 5 6 下一页尾页共有12页，转到页

期刊文章列表